|
Volume
21 Number 7
31 July 2019
|
|
Home
>
Publications
>
Current
Neuro-Oncology >
Volume
21, Year 2019 >
Number 7, 31 July
|
|
|
|
|
|
Shah
AH, Mahavadi AK, Morell A, Eichberg DG, Luther E, Sarkiss CA,
Semonche A, Ivan ME, Komotar RJ.
Salvage
craniotomy for treatment-refractory symptomatic cerebral radiation
necrosis.
Neurooncol
Pract.
2019
Jul 3, 2020;7(1):94-102∟.
doi: 10.1093/nop/npz028∟.
PMID:
32257288∟.
Observational study.
ˍ
|
|
|
|
Villani V, Pace A, Vidiri A, Tanzilli A, Sperati F, Terrenato I,
Mariantonia C, Casini B, Metro G, Maschio M, Tatiana K, Cognetti
F, Fabi A.
Phase II study of weekly
carboplatin in pretreated adult malignant gliomas.
J
Neurooncol. 2019 Jul 4, 2019;144(1):211-216∟.
doi: 10.1007/s11060-019-03223-x∟.
PMID: 31273578∟.
Interventional study. ˍ
|
|
|
|
Hardian RF, Goto T, Kuwabara H, Hanaoka Y, Kobayashi S, Kanno H,
Shimojo H, Horiuchi T, Hongo K.
An
autopsy case of widespread brain dissemination of glioblastoma
unnoticed by magnetic resonance imaging after treatment with
bevacizumab.
Surg Neurol Int. 2019 Jul 5,
2019;10:137∟.
doi: 10.25259/SNI-183-2019∟.
PMID: 31528472∟.
Case report. ˍ
|
|
|
|
Tien AC, Li J, Bao X, DeRogatis A, Kim S, Mehta S, Sanai N.
A
Phase 0 Trial of Ribociclib in Recurrent Glioblastoma Patients
Incorporating a Tumor Pharmacodynamic- and Pharmacokinetic-Guided
Expansion Cohort.
Clin Cancer Res. 2019 Jul 8,
2019;25(19):5777-5786∟.
doi: 10.1158/1078-0432.CCR-19-0133∟.
PMID: 31285369∟.
Interventional study. ˍ
|
|
|
|
Giovannini G, Pasini F, Orlandi N, Mirandola L, Meletti S.
Tumor-associated status epilepticus
in patients with glioma: Clinical characteristics and
outcomes.
Epilepsy Behav. 2019 Jul 9, 2019;101(Pt
B):106370∟.
doi: 10.1016/j.yebeh.2019.06.014∟.
PMID: 31300386∟.
Observational
study.
ˍ
|
|
|
|
Addeo R, Lamberti G, Simonetti G, Iodice P, Marinelli A, Montella
L, Cappabianca S, Gaviani P, Caraglia M, Prete SD, Silvani A.
Biweekly fotemustine schedule for
recurrent glioblastoma in the elderly: activity and toxicity
assessment of a multicenter study.
CNS Oncol. 2019
Jul 10, 2019;8(2):CNS32∟.
doi: 10.2217/cns-2019-0004∟.
PMID: 31290692∟.
Observational
study.
ˍ
|
|
|
|
Galanis E, Anderson SK, Twohy EL, Carrero XW, Dixon JG, Tran DD,
Jeyapalan SA, Anderson DM, Kaufmann TJ, Feathers RW, Giannini C,
Buckner JC, Anastasiadis PZ, Schiff D.
A
phase 1 and randomized, placebo-controlled phase 2 trial of
bevacizumab plus dasatinib in patients with recurrent
glioblastoma: Alliance/North Central Cancer Treatment Group
N0872.
Cancer. 2019 Jul 10,
2019;125(21):3790-3800∟.
doi: 10.1002/cncr.32340∟.
PMID: 31290996∟.
Interventional study. ˍ
|
|
|
|
Kameda-Smith MM, Wang A, Abdulhadi N, Voth R, Sergeant A, Maharaj
A, Bakhshinyan D, Adile AA, Pai AM, Ajani O, Yarascavitch B,
Alyman MC, Duckworth J, Samaan MC, Farrokhyar F, Singh SK, Fleming
A; Pediatric Brain Tumour Study Group.
Salvage
Therapy for Childhood Medulloblastoma: A Single Center
Experience.
Can J Neurol
Sci. 2019 Jul 11, 2019;46(4):403-414∟.
doi: 10.1017/cjn.2019.39∟.
PMID: 31293232∟.
Observational
study.
ˍ
|
|
|
|
Sharma M, Schilero C, Peereboom DM, Hobbs BP, Elson P, Stevens
GHJ, McCrae K, Nixon AB, Ahluwalia MS.
Phase
II study of Dovitinib in recurrent glioblastoma.
J
Neurooncol. 2019 Jul 11, 2019;144(2):359-368∟.
doi: 10.1007/s11060-019-03236-6∟.
PMID: 31292802∟.
Interventional
study. ˍ
|
|
|
|
Tini P, Nardone V, Pastina P, Marampon F, Sebaste L, Cerase A,
Tombolini V, Pirtoli L, Mazzei MA.
Is
a reduction of radiation dose feasible in patients affected by
glioblastoma undergoing radio-chemotherapy according to MGMT
promoter methylation status without jeopardizing survival?
Clin
Neurol Neurosurg. 2019 Jul 15, 2019;184:105445∟.
doi: 10.1016/j.clineuro.2019∟.105445.
PMID: 31325903∟.
Observational
study.
ˍ
|
|
|
|
Zhao YY, Chen SH, Hao Z, Zhu HX, Xing ZL, Li MH.
A
Nomogram for Predicting Individual Prognosis of Patients with
Low-Grade Glioma.
World
Neurosurg. 2019 Jul 15, 2019;130:e605-e612∟.
doi: 10.1016/j.wneu.2019.06.169∟.
PMID: 31319188∟.
Observational
study.
ˍ
|
|
|
|
Ordookhanian C, Amidon RF, Kaloostian PE.
Gliomatosis
Cerebri: A Unique Presentation with Accompanying Clinical
Nuance.
Cureus.
2019 Jul 16, 2019;11(7):e5149∟.
doi: 10.7759/cureus.5149∟.
PMID: 31528509∟.
Case
report. ˍ
|
|
|
|
Kumar
N, Kumar R, Sharma SC, Mukherjee A, Khandelwal N, Tripathi M,
Miriyala R, Oinam AS, Madan R, Yadav BS, Khosla D, Kapoor
R.
Impact
of volume of irradiation on survival and quality of life in
glioblastoma: a prospective, phase 2, randomized comparison of
RTOG and MDACC protocols.
Neurooncol
Pract. 2019 Jul 18, 2020;7(1):86-93∟.
doi: 10.1093/nop/npz024∟.
PMID: 32257287∟.
Interventional
study.
ˍ
|
|
|
|
Neftel
C, Laffy J, Filbin MG, Hara T, Shore ME, Rahme GJ, Richman AR,
Silverbush D, Shaw ML, Hebert CM, Dewitt J, Gritsch S, Perez EM,
Gonzalez Castro LN, Lan X, Druck N, Rodman C, Dionne D, Kaplan A,
Bertalan MS, Small J, Pelton K, Becker S, Bonal D, Nguyen QD,
Servis RL, Fung JM, Mylvaganam R, Mayr L, Gojo J, Haberler C,
Geyeregger R, Czech T, Slavc I, Nahed BV, Curry WT, Carter BS,
Wakimoto H, Brastianos PK, Batchelor TT, Stemmer-Rachamimov A,
Martinez-Lage M, Frosch MP, Stamenkovic I, Riggi N, Rheinbay E,
Monje M, Rozenblatt-Rosen O, Cahill DP, Patel AP, Hunter T, Verma
IM, Ligon KL, Louis DN, Regev A, Bernstein BE, Tirosh I, Suvà
ML.
An
Integrative Model of Cellular States, Plasticity, and Genetics for
Glioblastoma.
Cell.
2019 Jul 18, 2019;178(4):835-849.e21∟.
doi: 10.1016/j.cell.2019.06.024∟.
PMID: 31327527∟.
Laboratory
investigation. ˍ
|
|
|
|
Wen PY, Reardon DA, Armstrong TS, Phuphanich S, Aiken RD, Landolfi
JC, Curry WT, Zhu JJ, Glantz M, Peereboom DM, Markert J, LaRocca
R, O'Rourke DM, Fink K, Kim L, Gruber M, Lesser GJ, Pan E, Kesari
S, Muzikansky A, Pinilla C, Santos RG, Yu JS.
A
Randomized Double-Blind Placebo-Controlled Phase 2 Trial Of
Dendritic Cell Vaccine ICT-107 In Newly Diagnosed Patients With
Glioblastoma.
Clin
Cancer Res. 2019 Jul 18, 2019;25(19):5799-5807∟.
doi: 10.1158/1078-0432.CCR-19-0261∟.
PMID: 31320597∟.
Interventional
study.
ˍ
|
|
|
|
Kaley TJ, Panageas KS, Mellinghoff IK, Nolan C, Gavrilovic IT,
DeAngelis LM, Abrey LE, Holland EC, Lassman AB.
Phase
II trial of an AKT inhibitor (perifosine) for recurrent
glioblastoma.
J
Neurooncol. 2019 Jul 19, 2019 Sep;144(2):403-407∟.
doi: 10.1007/s11060-019-03243-7∟.
PMID: 31325145∟.
Interventional
study.
ˍ
|
|
|
|
Fleischmann DF, Unterrainer M, Corradini S, Rottler M, Förster
S, la Fougère C, Siepmann T, Schwaiger M, Bartenstein P,
Belka C, Albert NL, Niyazi M.
Report
of first recurrent glioma patients examined with PET-MRI prior to
re-irradiation.
PLoS
One. 2019 Jul 24, 2019;14(7):e0216111∟.
doi: 10.1371/journal.pone.0216111∟.
PMID: 31339892∟.
Interventional
study.
ˍ
|
|
|
|
Ricard JA, Cramer S, Charles R, Tommee CG, Le A, Bell WR, Chen C,
Flanagan ME.
Infratentorial
Glioblastoma Metastasis to Bone.
World
Neurosurg. 2019 Jul 26, 2019;131:90-94∟.
doi: 10.1016/j.wneu.2019.07.142∟.
PMID: 31356980∟.
Case
report. ˍ
|
|
|
|
Fukuya Y, Ikuta S, Maruyama T, Nitta M, Saito T, Tsuzuki S,
Chernov M, Kawamata T, Muragaki Y.
Tumor
recurrence patterns after surgical resection of intracranial
low-grade gliomas.
J
Neurooncol. 2019 Jul 30, 2019;144(3):519-528∟.
doi: 10.1007/s11060-019-03250-8∟.
PMID: 31363908∟.
Observational
study.
ˍ
|
|
|
|
Kim D, Wang N, Ravikumar V, Raghuram DR, Li J, Patel A, Wendt RE
3rd, Rao G, Rao A.
Prediction of
1p/19q Codeletion in Diffuse Glioma Patients Using Pre-operative
Multiparametric Magnetic Resonance Imaging.
Front
Comput Neurosci. 2019 Jul 30, 2019;13:52∟.
doi: 10.3389/fncom.2019.00052∟.
PMID: 31417387∟.
Observational
study.
ˍ
|
|
|
|
Valiyaveettil D, Malik M, Joseph
DM.
Effect
of radiation dose to the periventricular zone and subventricular
zone on survival in anaplastic gliomas.
Ecancermedicalscience.
2019 Jul 31, 2019;13:956∟.
doi: 10.3332/ecancer.2019.956? PMID: 31645884∟.
Observational
study.
ˍ
|
|
|
|
|
|
|
|
|
